Cafepharma Today

February 28 2025 - Lilly hops on hot molecular glue train with $1.6B+ Magnet deal
Lilly hops on hot molecular glue train with $1.6B+ Magnet deal
If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M
U.S. health agencies participated in WHO flu meeting despite planned exit
Teva targets schizophrenia to build on innovative medicines growth
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Nycomed submits Daxas lung drug for EU approval
Reuters
Friday, May 8, 2009 - 7:08am
tags:
Nycomed, Daxas
Glaxo's cervical cancer vaccine faces US battle
Yahoo/AP
Friday, May 8, 2009 - 7:00am
tags:
GSK, cervical cancer, Gardasil, vaccines, Cervarix
Is The FDA Easing Up?
Forbes
Friday, May 8, 2009 - 6:58am
tags:
FDA
FACTBOX-Drugs in development to prevent, treat influenza
Interactive Investor
Thursday, May 7, 2009 - 8:39pm
tags:
Flu, pipelines, drug development
Diabetes drug gets FDA nod, but who'll sell it?
Fierce Pharma
Thursday, May 7, 2009 - 8:37pm
tags:
FDA, Onglyza, diabetes, Cycloset, VeroScience
Exelixis 1Q loss narrows on lower costs
Yahoo/AP
Thursday, May 7, 2009 - 8:35pm
tags:
Exelixis, earnings
Dendreon Raising Cash
TheStreet.com
Thursday, May 7, 2009 - 5:31pm
tags:
Dendreon
Exelixis could get up to $354M in collaboration
Bizjournals.com
Thursday, May 7, 2009 - 5:30pm
tags:
Exelixis, partnerships, Boehringer Ingelheim
Isis Our Top Mid-Cap Biotech Pick
Yahoo/Zacks.com
Thursday, May 7, 2009 - 5:27pm
tags:
Isis Pharmaceuticals, biotech
Takeda to Start Sales and Marketing Operation in Portugal
Pharma Live
Thursday, May 7, 2009 - 10:51am
tags:
Takeda, Portugal, Europe
Is Amylin caving to proxy pressure?
Fierce Pharma
Thursday, May 7, 2009 - 10:29am
tags:
Amylin, diabetes
Shire Q1: The Big Fight Against Teva's Generics Begins
BNET Pharma
Thursday, May 7, 2009 - 10:27am
tags:
ADHD, Vyvanase, Adderall XR
Jazz Pharmaceuticals trims Q1 loss, misses payment
Bizjournals.com
Thursday, May 7, 2009 - 10:26am
tags:
Jazz Pharmaceuticals, earnings
Cheaper Generic Pills Saved US $734 Billion: Lobbyists
CNBC
Thursday, May 7, 2009 - 8:51am
tags:
generics, lobbying
Enzon Reports Strong 1st Quarter 2009 Results
Yahoo
Thursday, May 7, 2009 - 8:49am
tags:
Enzon, earnings
FDA Grants Priority Review Status to Prevnar 13 Marketing Application
Yahoo
Thursday, May 7, 2009 - 8:48am
tags:
FDA, Prevnar, Wyeth, vaccines
Sanofi-Aventis Bonds Trigger ‘Astonishing’ Demand, ING Says
Bloomberg
Thursday, May 7, 2009 - 6:28am
tags:
Sanofi, bonds
China drug maker Zensun eyes Nasdaq listing in 2011
Reuters, UK
Thursday, May 7, 2009 - 6:24am
tags:
China, Zensun, NASDAQ
Mixing Plavix, Heartburn Drugs Seen as Risky
WSJ Online
Thursday, May 7, 2009 - 6:21am
tags:
Plavix, heartburn, PPIs, Nexium
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
Yahoo
Thursday, May 7, 2009 - 6:20am
tags:
FDA, Vanda, schizophrenia, Fanapt

Pages

Latest CP Wire Articles

FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Latest Pharmagather Articles

Patient Care’s Next Big Shift: 80% of Leaders Say This Is the Game Changer
Drug Channels
Available for Preorder: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
The Thiazide Target, At Last
In the Pipeline
Drug Channels News Roundup, February 2025: Part D vs. Pharmacies, Accumulator Madness, Wholesaler Vertical Integration, IRA vs. MDs, and a 340B Cartoon
Drug Channels
Neurodegeneration Might Come Down to RNA
In the Pipeline
From Data Gaps to Revenue Gains: Harnessing the Power of Comprehensive Data to Drive GTN
Drug Channels
Paxlovid: You'd Have Expected More
In the Pipeline
The Continuing Crisis, Part V: What the NIH Is Telling Its People
In the Pipeline
What the Antifungals Are Really Doing
In the Pipeline

Latest Jobs

Clinical Account Executive
Sanford, Florida, 32771
SOFIE
Sales Representative
Airway Heights, Washington, 99001
Bartlett Roofing
Sales Representative
Spokane, Washington, 99208
Bartlett Roofing
Sales Representative - FT Spokane Valley, WA
Spokane, Washington, 99204
Bartlett Roofing
Sales Representative - FT Spokane Valley, WA
Otis Orchards, Washington, 99027
Bartlett Roofing
Sales Representative - Paid Training
Greenacres, Washington, 99016
Bartlett Roofing
Sales Representative - FT (Up to $150,000 annually)
Spokane, Washington, 99216
Bartlett Roofing
Sales Representative - FT (Up to $150,000 annually)
Veradale, Washington, 99037
Bartlett Roofing
Sales Representative - Paid Training
Otis Orchards, Washington, 99027
Bartlett Roofing
Sales Representative
SPOKANE VALLEY, Washington, 99027
Bartlett Roofing
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information